December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
The Penetration of Levofloxacin into Human Aqueous Humor
Author Affiliations & Notes
  • S Kobayakawa
    The 1st Dept of Ophthalmology Toho University Sch of Med Ohta-Ku Tokyo Japan
  • T Tochikubo
    The 1st Dept of Ophthalmology Toho University Sch of Med Ohta-Ku Tokyo Japan
  • Y Katayama
    The 1st Dept of Ophthalmology Toho University Sch of Med Ohta-Ku Tokyo Japan
  • H Watanabe
    The 1st Dept of Ophthalmology Toho University Sch of Med Ohta-Ku Tokyo Japan
  • Footnotes
    Commercial Relationships   S. Kobayakawa, None; T. Tochikubo, None; Y. Katayama, None; H. Watanabe, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2321. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S Kobayakawa, T Tochikubo, Y Katayama, H Watanabe; The Penetration of Levofloxacin into Human Aqueous Humor . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2321.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: This study was designed to measure the concentration of levofloxacin (LVFX) in aqueous humor after topical and oral administration in 101 patients undergoing cataract extraction. Method: In Group 1(N=32), 0.5% LVFX eyedrops were topically instilled five times every 30 minutes for 2 hours before the surgery. In Group 2(N=35), the patients received a single oral dose of 200 mg LVFX two hours before surgery. In Group 3(N=34), the patients received total 600mg LVFX (two 100-mg tablets, administered 18, 6, and 2 hours preceding surgery) before surgery. Aqueous humor ( 0.1ml-0.15ml) were collected before the anterior capsulotomy of each case from the cornea side port, and concentration of LVFX in aqueous humor were measured by the high performance liquid chromatograhy method (HPLC). Results: LVFX concentration in the aqueous humor of group 1 (instillation ) is 0.69±0.37µg/ml, and group 2 (oral administration 1 time ) were 0.42±0.19µg/ml, group 3 (oral administration 3 times) were 1.30±0.53µg/ml. There was a significant difference between Group 3 and Group 1,2 (p<0.0001). Conclusion: As a result, orally applied 600mg LVFX achieved a significant aqueous concentration. The aqueous humor levels of 600mg LVFX after oral route exceed the minimum inhibitory concentrations for certain bacterial species that frequently cause intraocular infection.

Keywords: 324 aqueous • 319 antibiotics/antifungals/antiparasitics • 357 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×